As indicated in Figure 1E, the overexpression of FMO1 was significantly related to a worse prognosis in GC [hazard ratio (HR) =1.112, p = 0.045], while FMO2 had no significant effect on prognosis (HR = 1.185, p = 0.067). The gene discussed is FMO1; the disease is gastric cancer.